Oncology Pipeline
PharmaMar in the World
Other Businesses
Biopharmaceutical Sector
 |
 |
Investors
PharmaMar provides you all the financial information possible regarding our activities on the BME exchange, historical quarterly and annual information.
- 26/06/2019 Composition of the board of directors
- 26/06/2019 Transmissions and purchases of capital undertakings
- 26/06/2019 Announcements and resolutions of general shareholders meetings
- 26/06/2019 Strategic plans, profit forecasts and presentations
- 01/06/2019 R&D: new licenses, patents and registered trademarks
- 23/05/2019 Announcements and resolutions of general shareholders meetings
- 23/05/2019 Transmissions and purchases of capital undertakings
- 16/05/2019 R&D: new licenses, patents and registered trademarks
- 15/05/2019 R&D: new licenses, patents and registered trademarks
- 26/04/2019 Credit ratings
- 26/04/2019 Information on P&L
- 26/04/2019 Strategic agreements with third parties
- 04/04/2019 Liquidity contracts and specialists
- 01/04/2019 R&D: new licenses, patents and registered trademarks
- 25/03/2019 R&D: new licenses, patents and registered trademarks
- 29/02/2019 Announcements of public presentations and meetings
- 28/02/2019 Information on P&L
-
Financial
Information -
PharmaMar provides you all the financial information possible regarding our activities on the BME exchange, historical quarterly and annual information.
-
Official Notices
to the CNMV -
- 26/06/2019 Composition of the board of directors
- 26/06/2019 Transmissions and purchases of capital undertakings
- 26/06/2019 Announcements and resolutions of general shareholders meetings
- 26/06/2019 Strategic plans, profit forecasts and presentations
- 01/06/2019 R&D: new licenses, patents and registered trademarks
- 23/05/2019 Announcements and resolutions of general shareholders meetings
- 23/05/2019 Transmissions and purchases of capital undertakings
- 16/05/2019 R&D: new licenses, patents and registered trademarks
- 15/05/2019 R&D: new licenses, patents and registered trademarks
- 26/04/2019 Credit ratings
- 26/04/2019 Information on P&L
- 26/04/2019 Strategic agreements with third parties
- 04/04/2019 Liquidity contracts and specialists
- 01/04/2019 R&D: new licenses, patents and registered trademarks
- 25/03/2019 R&D: new licenses, patents and registered trademarks
- 29/02/2019 Announcements of public presentations and meetings
- 28/02/2019 Information on P&L
-
Share
Information -
Corporate
Presentations
Contact
PHARMA MAR, S.A.
Avda. de los Reyes, 1
Pol. Ind. La Mina, 28770
Colmenar Viejo, Madrid, Spain
VAT: ESA-78267176
|
|
|
|
If you wish to inform on an adverse event, please click here
#PharmaMar es la compañía con la biblioteca de #organismos marinos más grande del mundo, con más de 200.000 ejemplares. Es or eso que ha decidido centrar su actividad en la #investigación oncológica.
https://t.co/l7IneMbIzX
El VPH está detrás del 99% de los casos de #cáncerdeútero, por lo que la prevención en la detección de este virus es fundamental en la #luchacontraelcáncer. La vacuna del #VPH es una medida de prevención para frenar el desarrollo del cáncer de útero.
https://t.co/qB798CFQP9
Hoy, 13 de julio, es el Día Internacional del Sarcoma. Desde aquí queremos enviar todo nuestro apoyo a las personas que se ven afectadas por esta enfermedad y agradecer la labor de asociaciones como @AEASARCOMA por hacer más fácil el camino #Sarcomaawareness #DMSarcoma https://t.co/ZRnihT5K7B
Newsletter
Subscribe to our newsletter and you will receive the latest news about PharmaMar, information about new advances, data for investors, and much more.